论文部分内容阅读
目的观察经支气管镜气道内球囊压迫术治疗呼吸道大咯血的临床疗效及不良反应。方法选取我院2009年8月-2012年4月诊治的60例呼吸道大咯血的患者,随机分为球囊压迫组及支气管动脉栓塞组各30例,观察两组临床疗效、止血时间、住院费用、住院天数、复发率及并发症。结果球囊组的临床总有效率达90%,优于栓塞组(83.3%),但组间差异无统计学意义(P>0.05),止血时间为2.6±0.93h,显著低于栓塞组(5.9±1.37)h,差异有统计学意义(P<0.05);两组的住院天数比较无统计学差异(P>0.05);随访5-8个月,球囊组患者咯血的复发率为20%,稍高于栓塞组(13.3%),但差异无统计学意义(P>0.05),并发肺不张、咳嗽等发生率为26.6%,高于栓塞组(13.3%),但差异无统计学意义(P>0.05)。结论纤维支气管镜气道内球囊压迫治疗呼吸道大咯血,操作简便、起效快且效果显著,值得临床推广应用。
Objective To observe the clinical efficacy and adverse reactions of endobronchial balloon compression in the treatment of massive hemoptysis of the respiratory tract. Methods Sixty patients with massive hemoptysis of respiratory tract treated in our hospital from August 2009 to April 2012 were randomly divided into balloon compression group and bronchial artery embolization group, 30 cases each. The clinical curative effect, bleeding time, hospitalization cost , Days of hospitalization, recurrence rate and complications. Results The total effective rate of the balloon group was 90%, which was better than that of the embolization group (83.3%), but there was no significant difference between the two groups (P> 0.05). The bleeding time was 2.6 ± 0.93 h, significantly lower than that of the embolization group 5.9 ± 1.37) h, the difference was statistically significant (P <0.05). There was no significant difference in the days of hospitalization between the two groups (P> 0.05). The recurrence rate of hemoptysis in the balloon group was 20 %, Slightly higher than the embolization group (13.3%), but the difference was not statistically significant (P> 0.05). The incidence of atelectasis and cough was 26.6%, higher than that of the embolization group (13.3%), but the difference was not statistically significant Significance (P> 0.05). Conclusions Fiberoptic bronchoscopy is an effective and safe method for the treatment of massive hemoptysis of the respiratory tract by balloon compression. It is worthy of clinical application.